The Percheron Therapeutics (ASX:PER) board of directors has written a letter to shareholders following failure of its phase 2b trial of lead candidate avicursen (ATL-1102) into non-ambulant (unable to ...
Maintaining mental clarity, focus, and memory is essential to navigating daily life in a world where cognitive function is ...
Navigating an over-cluttered market of weight loss supplements can feel challenging, especially when every product claims to ...
Saman Gunatilake Emeritus Professor of Medicine and Neurologist University of Sri Jayewardenepura Key facts * Substandard and ...
It’s been an eventful year for Texas hook and bullet crowds. Among other things, we saw the opening of the first new major ...